Results 1 to 10 of about 14,216 (180)

Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study

Endocrine Journal, 2023
CA19-9 is a tumor marker for pancreatic cancer (PC), and the nondiabetic cut-off level is 37 U/mL. CA19-9 levels are said to rise in patients with tumors like PC and intraductal papillary mucinous neoplasm (IPMN). CA19-9 levels have also been shown to be
Taku Yamada, Taichi Minami, Masayo Yamada, Yasuo Terauchi   +3 more
doaj   +5 more sources

Carbohydrate antigen 19-9-producing splenic cyst: a case report [PDF]

Radiology Case Reports, 2022
We describe the case of a 40s woman with a carbohydrate antigen (CA)19-9-producing splenic cyst. The lesion was detected incidentally at the splenic hilum, and resected after 5 years of follow-up.
Norihiro Shinkawa, MD, PhD, Hiromi Horinouchi, MD, Ninako Shinkawa, MD, Naoya Imamura, MD, PhD, Tsuyoshi Fukushima, MD, PhD   +4 more
doaj   +5 more sources

Prognostic significance of carbohydrate antigen 19-9 (CA19-9) change during immediate postoperative periods in patients with stage I–III colorectal cancer [PDF]

Annals of Coloproctology
Purpose Although carbohydrate antigen 19-9 (CA19-9) may exhibit low sensitivity in tumor screening, its prognostic significance has been highlighted. This study assessed the significance of preoperative CA19-9 and early postoperative CA19-9 levels in ...
Wooram Choi, Yongjung Park, Jeonghyun Kang   +2 more
doaj   +4 more sources

Metastatic papillary thyroid carcinoma presenting with elevated serum levels of carbohydrate antigen 19-9 (CA19-9): a case report. [PDF]

Surg Case Rep, 2022
Abstract Background The major sites of distant metastases of papillary thyroid carcinoma (PTC) are the lung and bone; metastasis to the liver is rare. Although the postoperative serum thyroglobulin (Tg) level after total thyroidectomy is a good prognostic indicator for PTC when anti-thyroglobulin antibody (TgAb) is ...
Kihara M, Miyauchi A, Hirokawa M, Fujishima M, Masuoka H, Higashiyama T, Onoda N, Ito Y, Miya A.   +8 more
europepmc   +4 more sources

Availability of Serum Levels of Carbohydrate Antigen 19-9 (CA19-9) as a Surrogate Tumor Marker for Papillary Thyroid Carcinoma. [PDF]

JMA J
Thyroglobulin (Tg) is a very sensitive and specific marker in patients who have undergone total thyroidectomy for papillary thyroid carcinoma (PTC). However, the presence of a Tg antibody (TgAb) interferes with Tg immunometric assays, making Tg levels unreliable indicators.
Kihara M, Miyauchi A, Hirokawa M, Suzuki A, Akamizu T.   +4 more
europepmc   +3 more sources

Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma [PDF]

Iranian Journal of Medical Sciences, 2023
Background: Pancreatic cancer is a malignancy with high mortality due to the difficulties in early detection. We investigated and compared the diagnostic and prognostic performance of several blood biomarkers, including microRNA-25 (miR-25), carbohydrate
Yan Gong, Lele Song, Lei Ou, You-Yong Lu, Xianyong Huang, Qiang Zeng   +5 more
doaj   +3 more sources

Mirrizi Syndrome and Markedly Elevated Levels of Carbohydrate Antigen 19-9 in the Absence of Malignant Disease [PDF]

Case Reports in Gastrointestinal Medicine, 2017
Elevated carbohydrate antigen 19-9 (CA19-9) beyond 1000 U/L occurs in nonneoplastic conditions which is causing questioning of the use of CA19-9 as a marker for screening.
Natasha Shah, Eula Tetangco, Hafiz Muhammad Sharjeel Arshad, Hareth Raddawi   +3 more
doaj   +2 more sources

A Capacitive Biosensor for the Early Detection of Pancreatic Cancer Using Carbohydrate Antigen 19-9 [PDF]

Engineering Proceedings, 2022
Pancreatic cancer has one of the highest cancer mortality rates, as it is often detected in late stages, when unresectable tumours are present. Researchers have identified a biomarker associated with the early detection of pancreatic cancer, called ...
Taskeen Ebrahim, Willem Perold, Anna-Mart Engelbrecht   +2 more
doaj   +3 more sources

Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study. [PDF]

Br J Surg
Abstract Background Which patients with locally advanced pancreatic cancer may benefit from surgical exploration after induction treatment remains debated. The aim of this retrospective cohort study was to identify independent factors for overall survival after surgical exploration for locally ...
Dekker EN, van Klaveren D, Verkolf EMM, de Wilde RF, Besselink MG, O'Reilly EM, Paniccia A, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Trans-Atlantic Pancreatic Surgery (TAPS) Consortium.   +12 more
europepmc   +5 more sources

Carbohydrate antigen 19‐9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine‐containing chemotherapy [PDF]

Cancer, 2013
BACKGROUND: Carbohydrate antigen 19‐9 (CA19‐9) is a widely used biomarker in pancreatic cancer. There is no consensus on the interpretation of the change in CA19‐9 serum levels and its role in the clinical management of patients with pancreatic cancer.
Todd M Bauer, Bassel F El-Rayes, Nazik Hammad   +2 more
exaly   +2 more sources